RETATRUTIDE: THE EMERGING WEIGHT LOSS PEPTIDE?

Recent research suggests retatrutide, a novel dual-action peptide, could be a major development in weight loss . This agent works by targeting both the GLP-1 and GIP receptors, potentially offering a enhanced impact than current GLP-1 receptor medications . Initial clinical studies have shown